Core Group members


Alexander (Ander) T. Cohen


Dr Cohen is a consultant physician and epidemiologist at Guy's and St Thomas' Hospitals NHS Foundation Trust and King's College London.  He is involved in designing, managing, and analysing clinical trials from phase I to IV, and in international steering committees for multicentre trials. His main interests continue to be in the screening for and the prevention of vascular disease. He specializes in the primary and secondary prevention of cardiovascular disease, prevention of stroke and coronary artery disease, and prophylaxis and treatment of venous thromboembolism (VTE).  He has participated in cardiovascular clinical trials for low-molecular-weight heparins, factor X inhibitors such as pentasaccharides and oral agents including the DOACs (NOACs), parenteral and oral thrombin inhibitors, and thrombolytic, antiplatelet, and lipid-lowering drugs.  He is currently investigating the use of FXI inhibitors and also AI in VTE and AF.

Dr Cohen graduated with honours in Medicine and honours in Surgery from the University of Melbourne, Australia, and became a fellow of the Royal Australasian College of Physicians in 1990. He was awarded an MSc in epidemiology from the London School of Hygiene and Tropical Medicine, University of London, in 1991 with a thesis on the metabolic syndrome in South Asian populations. In 1998, he was awarded an MD with a thesis on the epidemiology of venous thromboembolism and thromboprophylaxis. He is a Fellow of the European Society of Cardiology.

Dr Cohen is a member of the International Union of Angiology, the International Society on Thrombosis and Haemostasis, the British Society for Haemostasis and Thrombosis, the Cochrane Review Group for Systematic Reviews, the Internal Medicine Society of Australia and New Zealand, and the Formulary Committee at Guy’s, King's College, Lewisham and St Thomas’ Hospitals, UK. He has written or co-authored over 400 papers and abstracts since 1990, many in The Lancet, New England Journal of Medicine and BMJ. He is a regular editor for the peer-reviewed journals Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, and The Lancet, and a reviewer for the National Health Service (NHS) Centre for Reviews and Dissemination and the Drug and Therapeutics Bulletin. He is an advisor, as a vascular physician and epidemiologist, to the UK Government Health Select Committee, the all-party working group on thrombosis, the Department of Health, and the National Health Service, on the prevention of venous thromboembolism. He is also an advisor to Lifeblood: The Thrombosis Charity, and is the founder of the European educational charity the Coalition to Prevent Venous ThromboEmbolism.

© 2012 VTE   |   Disclaimer